Extracellular 2′,3′-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cells

American Journal of Physiology - Renal Physiology

Volumn 304, Issue 1, 2013, Pages

  Jackson, Edwin K ^a   Gillespie, Delbert G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

2 ,3 cAMP; 2 AMP; 3 amp; Collecting duct epithelial cells; Proximal tubular epithelial cells; Thick ascending limb epithelial cells

Indexed keywords

1,3 DIPROPYL 8 (4 SULFOPHENYL)XANTHINE; ADENOSINE 2' PHOSPHATE; ADENOSINE 2',3' PHOSPHATE; ADENOSINE 3' PHOSPHATE; ADENOSINE PHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ISOBUTYLMETHYLXANTHINE; 1,3-DIPROPYL-8-(4-SULFOPHENYL)XANTHINE; 2' ADENYLIC ACID; 2',3'-CYCLIC AMP; 2'-ADENYLIC ACID; ADENINE NUCLEOTIDE; ADENOSINE; ADENOSINE DIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE DIPHOSPHATE; ALPHA,BETA-METHYLENEADENOSINE 5'-DIPHOSPHATE; DRUG DERIVATIVE; XANTHINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL METABOLISM; HENLE LOOP; KIDNEY COLLECTING TUBULE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MALE; NEPHRON; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT; ANIMAL; BIOSYNTHESIS; EPITHELIUM CELL; METABOLISM; SPRAGUE DAWLEY RAT;

1-METHYL-3-ISOBUTYLXANTHINE; ADENINE NUCLEOTIDES; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ANIMALS; EPITHELIAL CELLS; KIDNEY TUBULES, COLLECTING; KIDNEY TUBULES, PROXIMAL; LOOP OF HENLE; MALE; RATS; RATS, SPRAGUE-DAWLEY; XANTHINES;

MLCS; MLOWN;

EID: 84871902615     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00571.2012     Document Type: Article

References (31)

1. Bauerle JD, Grenz A, Kim JH, Lee HT, Eltzschig HK. Adenosine generation and signaling during acute kidney injury. J Am Soc Nephrol 22: 14-20, 2011.
2. Beavo JA, Reifsnyder DH. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 11: 150-155, 1990.
3. Day YJ, Huang L, Ye H, Linden J, Okusa MD. Renal ischemiareperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Renal Physiol 288: F722-F731, 2005.
4. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 364: 656-665, 2011.
5. Grenz A, Bauerle JD, Dalton JH, Ridyard D, Badulak A, Tak E, McNamee EN, Clambey E, Moldovan R, Reyes G, Klawitter J, Ambler K, Magee K, Christians U, Brodsky KS, Ravid K, Choi DS, Wen J, Lukashev D, Blackburn MR, Osswald H, Coe IR, Nurnberg B, Haase VH, Xia Y, Sitkovsky M, Eltzschig HK. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest 122: 693-710, 2012.
6. Grenz A, Osswald H, Eckle T, Yang D, Zhang H, Tran ZV, Klingel K, Ravid K, Eltzschig HK. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med 5: e137, 2008.
7. Grenz A, Zhang H, Hermes M, Eckle T, Klingel K, Huang DY, Muller CE, Robson SC, Osswald H, Eltzschig HK. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J 21: 2863-2873, 2007
8. Jackson EK, Gillespie DG. Extracellular 2′,3′-cAMP and 3′,5′-cAMP stimulate proliferation of preglomerular vascular endothelial cells and renal epithelial cells. Am J Physiol Renal Physiol 303: F954-F962, 2012.
9. Jackson EK, Gillespie DG, Dubey RK. 2′-AMP and 3′-AMP inhibit proliferation of preglomerular vascular smooth muscle cells and glomerular mesangial cells via A2B receptors. J Pharmacol Exp Ther 337: 444-450, 2011.
10. Jackson EK, Mi Z, Zhu C, Dubey RK. Adenosine biosynthesis in the collecting duct. J Pharmacol Exp Ther 307: 888-896, 2003.
11. Jackson EK, Ren J, Cheng D, Mi Z. Extracellular cAMP-adenosine pathways in the mouse kidney. Am J Physiol Renal Physiol 301: F565-F573, 2011.
12. Jackson EK, Ren J, Gillespie DG. 2′,3′-cAMP, 3′-AMP and 2′-AMP inhibit human aortic and coronary vascular smooth muscle cell proliferation via A2B receptors. Am J Physiol Heart Circ Physiol 301: H391-H401, 2011.
13. Jackson EK, Ren J, Gillespie DG, Dubey RK. Extracellular 2′,3′-cyclic adenosine 5′-monophosphate is a potent inhibitor of preglomerular vascular smooth muscle cell and mesangial cell growth. Hypertension 56: 151-158, 2010.
14. Jackson EK, Ren J, Mi Z. Extracellular 2′,3′-cAMP is a source of adenosine. J Biol Chem 284: 33097-33106, 2009.
15. Jackson EK, Zacharia LC, Zhang M, Gillespie DG, Zhu C, Dubey RK. cAMP-adenosine pathway in the proximal tubule. J Pharmacol Exp Ther 317: 1219-1229, 2006.
16. Kim M, Chen SWC, Park SW, Kim M, D'Agati VD, Yang J, Lee HT. Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury. Kidney Int 75: 809-823, 2009.
17. Lee HT, Emala CW. Adenosine attenuates oxidant injury in human proximal tubular cells via A1 and A2a adenosine receptors. Am J Physiol Renal Physiol 282: F844-F852, 2002.
18. Lee HT, Emala CW. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A1 and A3 receptors. Am J Physiol Renal Physiol 278: F380-F387, 2000.
19. Lee HT, Kim M, Jan M, Penn RB, Emala CW. Renal tubule necrosis and apoptosis modulation by A1 adenosine receptor expression. Kidney Int 71: 1249-1261, 2007.
20. Lu B, Rajakumar SV, Robson SC, Lee EKF, Crikis S, d'Apice AJF, Cowan PJ, Dwyer KM. The impact of purinergic signaling on renal ischemia-reperfusion injury. Transplantation 86: 1707-1712, 2008.
21. Mi Z, Jackson EK. Metabolism of exogenous cyclic AMP to adenosine in the rat kidney. J Pharmacol Exp Ther 273: 728-733, 1995.
22. Okusa MD. A2A adenosine receptor: a novel therapeutic target in renal disease. Am J Physiol Renal Physiol 282: F10-F18, 2002.
23. Okusa MD, Linden J, Huang L, Rieger JM, Macdonald TL, Huynh LP. A2A adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol 279: F809-F818, 2000.
24. Okusa MD, Linden J, Huang L, Rosin DL, Smith DF, Sullivan G. Enhanced protection from renal ischemia-reperfusion injury with A2Aadenosine receptor activation and PDE 4 inhibition. Kidney Int 59: 2114-2125, 2001.
25. Okusa MD, Linden J, Macdonald T, Huang L. Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol Renal Physiol 277: F404-F412, 1999.
26. Park SW, Kim JY, Ham A, Brown KM, Kim M, D'Agati VD, Lee HT. A1 adenosine receptor allosteric enhancer PD-81723 protects against renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 303: F721-F732, 2012.
27. Ren J, Mi Z, Stewart NA, Jackson EK. Identification and quantification of 2′,3′-cAMP release by the kidney. J Pharmacol Exp Ther 328: 855-865, 2009.
28. Tofovic SP, Branch KR, Oliver RD, Magee WD, Jackson EK. Caffeine potentiates vasodilator-induced renin release. J Pharmacol Exp Ther 256: 850-860, 1991
29. Verrier JD, Exo JL, Jackson TC, Ren J, Gillespie DG, Dubey RK, Kochanek PM, Jackson EK. Expression of the 2′,3′-cAMP-adenosine pathway in astrocytes and microglia. J Neurochem 118: 979-987, 2011.
30. Zacher LA, Carey GB. cAMP metabolism by swine adipocyte microsomal and plasma membranes. Comp Biochem Physiol B Biochem Mol Biol 124: 61-71, 1999.
31. Zimmermann H. 5′-Nucleotidase: molecular structure and functional aspects. Biochem J 285: 345-365, 1992.